Skip to main content

Harmony Biosciences Holdings, Inc.

HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802665

In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Harmony Biosciences Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
1 insider, $3.11M in total
Insiders trading
1
Net value
−$3.11M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Harmony Biosciences Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Harmony Biosciences Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Budur KumarCHIEF MEDICAL OFFICER13,115Sep 18, 20264
Germano Geno JDirector–May 18, 20261
Graf R. MarkDirector–May 18, 20261
Sender GaryDirector–May 18, 20261
Szyper Linda MDirector–May 18, 20261
Reicin GlennCHIEF FINANCIAL OFFICER–May 18, 20261
Sabater Juan A.Director0May 18, 20261
Philip Ron MDirector–May 18, 20261
Zaeske Adam H.CHIEF COMMERCIAL OFFICER4,327Apr 9, 20262
Ignelzi Troy A.Director–Apr 6, 20261
Anastasiou PeterCHIEF OPERATING OFFICER–Apr 6, 20261
Kapadia SandipCHIEF FINANCIAL OFFICER24,521Jan 28, 20266
Dayno Jeffrey M.PRESIDENT, CEO7,346Jan 26, 20262
Serafin AndrewCHIEF STRATEGY OFFICER1,474Jan 26, 20261
Gracias Antonio J.Director, 10% Owner0Sep 2, 20250
Valor Equity Partners IV L.P.10% Owner0Sep 2, 20250
Valor Equity Partners IV-B L.P.10% Owner0Sep 2, 20250
Valor Equity Partners IV-A L.P.10% Owner0Sep 2, 20250
Valor IV Pharma Holdings, LLC10% Owner0Sep 2, 20250
Valor Equity Capital IV LLC10% Owner0Sep 2, 20250
Valor Equity Associates IV L.P.10% Owner0Sep 2, 20250
Valor Management L.P.10% Owner0Sep 2, 20250
Dierks JeffreyCHIEF COMMERCIAL OFFICER0Mar 5, 20250
Marshman Fund Trust II10% Owner6,051,120Nov 5, 20240
Nielsen JackDirector2,571,024IndirectMay 31, 20240
Wicki AndreasDirector2,147,943IndirectDec 14, 20220
Jacobs John CPRESIDENT, CEO0Aug 16, 20220
Aronin Jeffrey SDirector251,922Mar 28, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2026 (view filing)4:48 PM ETSep 16-182 daysBudur KumarCHIEF MEDICAL OFFICERSSale−38.5K$43.05−$1.66M−74.6%13.1K after3 lots
Sep 9, 2026 (view filing)5:12 PM ETSep 4-85 daysBudur KumarCHIEF MEDICAL OFFICERSSale−34.0K$42.80−$1.45M−72.1%13.1K after4 lots
Jan 28, 2026 (view filing)Jan 262 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−3.75K$37.15−$139.2K−13.3%24.5K after10b5-1
Jan 20, 2026 (view filing)Jan 155 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−21.0K$35.92−$752.9K−100.0%0 after10b5-1
Dec 17, 2025 (view filing)Dec 125 daysLateDayno Jeffrey M.PRESIDENT, CEOSSale−25.9K$40.11−$1.04M−100.0%0 after2 lots10b5-1
Dec 9, 2025 (view filing)Dec 54 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−20.0K$39.54−$790.8K−100.0%0 after10b5-1
Nov 25, 2025 (view filing)Nov 214 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−3.43K$35.00−$119.9K−100.0%0 after10b5-1
Aug 19, 2025 (view filing)Aug 154 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−21.6K$36.50−$787.4K−100.0%0 after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−6.99K$32.55−$227.4K−100.0%0 after2 lots10b5-1
Mar 5, 2025 (view filing)Mar 32 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−4.87K$32.67−$159.1K−100.0%0 after2 lots10b5-1
Jan 28, 2025 (view filing)Jan 24-274 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−14.8K$37.38−$551.5K−100.0%0 after3 lots10b5-1
Jan 28, 2025 (view filing)Jan 271 dayKapadia SandipCHIEF FINANCIAL OFFICERSSale−1.77K$38.05−$67.5K−100.0%0 after10b5-1
Jan 23, 2025 (view filing)Jan 212 daysDayno Jeffrey M.PRESIDENT, CEOSSale−19.3K$40.13−$774.2K−100.0%0 after10b5-1
Jan 23, 2025 (view filing)Jan 212 daysKapadia SandipCHIEF FINANCIAL OFFICERSSale−25.0K$40.18−$1.00M−100.0%0 after10b5-1
Jan 21, 2025 (view filing)Jan 16-215 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−30.6K$37.51−$1.15M−100.0%0 after2 lots10b5-1
Jan 16, 2025 (view filing)Jan 151 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−10.5K$37.01−$388.9K−100.0%0 after10b5-1
Jan 15, 2025 (view filing)Jan 132 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−7.18K$37.04−$265.9K−100.0%0 after10b5-1
Nov 5, 2024 (view filing)5:48 PM ETNov 1-54 daysGracias Antonio J. and 8 othersDirector, 10% OwnerSSale−4.60M$30.30−$139.4M−41.0%6.62M after2 lots
Nov 5, 2024 (view filing)Nov 1-54 daysMarshman Fund Trust II10% OwnerSSale−4.60M$30.30−$139.4M−43.2%6.05M after2 lots
Oct 31, 2024 (view filing)Oct 292 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−21.5K$40.47−$869.9K−100.0%0 after10b5-1
Oct 7, 2024 (view filing)Oct 34 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−36.4K$35.06−$1.27M−100.0%0 after2 lots
Oct 2, 2024 (view filing)Oct 11 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−400$40.19−$16.1K−100.0%0 after
Oct 1, 2024 (view filing)Sep 301 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−35.8K$40.03−$1.43M−100.0%0 after
Sep 30, 2024 (view filing)Sep 273 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−200$40.05−$8.01K−100.0%0 after
Mar 18, 2024 (view filing)Mar 153 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−12.0K$32.00−$383.3K−100.0%0 after
Mar 11, 2024 (view filing)Mar 83 daysDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−194$32.00−$6.21K−100.0%0 after
Dec 16, 2022 (view filing)Dec 142 daysNielsen JackDirectorSSale−2.83K$59.96−$169.9K−0.1%2.57M after
Dec 14, 2022 (view filing)Dec 12-142 daysWicki AndreasDirectorSSale−28.8K$60.31−$1.74M−1.3%2.15M after3 lots
Dec 9, 2022 (view filing)Dec 7-92 daysNielsen JackDirectorSSale−110.8K$60.16−$6.66M−4.1%2.57M after3 lots
Dec 7, 2022 (view filing)Dec 52 daysWicki AndreasDirectorSSale−77.9K$61.23−$4.77M−3.5%2.18M after
Dec 5, 2022 (view filing)Dec 23 daysSerafin AndrewCHIEF STRATEGY OFFICERSSale−38.0K$60.13−$2.29M−100.0%0 after2 lots
Dec 1, 2022 (view filing)Nov 29-Dec 12 daysNielsen JackDirectorSSale−129.7K$59.29−$7.69M−4.6%2.68M after3 lots
Nov 22, 2022 (view filing)Nov 18-224 daysNielsen JackDirectorSSale−77.6K$57.27−$4.44M−2.7%2.81M after3 lots
Nov 16, 2022 (view filing)Nov 14-152 daysWicki AndreasDirectorSSale−51.3K$59.31−$3.04M−2.2%2.25M after2 lots
Nov 15, 2022 (view filing)Nov 11-154 daysNielsen JackDirectorSSale−158.4K$57.58−$9.12M−5.2%2.89M after3 lots
Nov 10, 2022 (view filing)Nov 8-102 daysWicki AndreasDirectorSSale−129.4K$58.89−$7.62M−5.3%2.31M after3 lots
Nov 4, 2022 (view filing)Nov 31 dayDayno Jeffrey M.CHIEF MEDICAL OFFICERSSale−15.0K$60.02−$900.3K−100.0%0 after
Nov 4, 2022 (view filing)Nov 2-42 daysWicki AndreasDirectorSSale−576.8K$59.09−$34.1M−19.1%2.44M after3 lots
Nov 2, 2022 (view filing)Nov 11 dayDayno Jeffrey M.CHIEF MEDICAL OFFICERSSale−15.0K$55.10−$826.5K−100.0%0 after
Oct 4, 2022 (view filing)Oct 31 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−12.2K$44.68−$543.9K−100.0%0 after2 lots
Aug 23, 2022 (view filing)Aug 221 dayDierks JeffreyCHIEF COMMERCIAL OFFICERSSale−29.0K$47.00−$1.36M−100.0%0 after2 lots
Aug 16, 2022 (view filing)Aug 151 dayJacobs John CPRESIDENT, CEOSSale−40.0K$51.07−$2.04M−100.0%0 after2 lots
Aug 10, 2022 (view filing)Aug 8-102 daysWicki AndreasDirectorSSale−578.6K$53.77−$31.1M−16.1%3.01M after3 lots
Aug 8, 2022 (view filing)Aug 4-84 daysNielsen JackDirectorSSale−250.0K$52.73−$13.2M−7.6%3.05M after3 lots
Aug 5, 2022 (view filing)Aug 3-52 daysWicki AndreasDirectorSSale−72.6K$52.73−$3.83M−2.0%3.59M after3 lots
Aug 3, 2022 (view filing)Aug 21 dayNielsen JackDirectorSSale−75.1K$55.22−$4.15M−2.2%3.30M after
Jul 20, 2022 (view filing)Jul 182 daysNielsen JackDirectorSSale−40.1K$55.19−$2.21M−1.2%3.38M after
Jul 15, 2022 (view filing)Jul 132 daysNielsen JackDirectorSSale−5.77K$55.04−$317.7K−0.2%3.42M after
Jul 12, 2022 (view filing)Jul 8-114 daysNielsen JackDirectorSSale−10.8K$55.05−$592.8K−0.3%3.42M after2 lots
Jul 7, 2022 (view filing)Jul 5-72 daysNielsen JackDirectorSSale−300.7K$55.39−$16.7M−8.1%3.43M after3 lots